On the cytotoxic activity of Pd(II) complexes of N,N-disubstituted-N′-acyl thioureas by Plutín, Ana M. et al.
  Universidade de São Paulo
 
2014-05
 
On the cytotoxic activity of Pd(II) complexes of
N,N-disubstituted-N-acyl thioureas
 
 
Journal of Inorganic Biochemistry,Philadelphia : Elsevier,v. 134, p. 76-82, May 2014
http://www.producao.usp.br/handle/BDPI/50420
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Departamento de Física e Ciência Interdisciplinar - IFSC/FCI Artigos e Materiais de Revistas Científicas - IFSC/FCI
On the cytotoxic activity of Pd(II) complexes of
N,N-disubstituted-N′-acyl thioureas
Ana M. Plutín a,⁎, Raúl Mocelo a, Anislay Alvarez a, Raúl Ramos a, Eduardo E. Castellano b, Marcia R. Cominetti c,
Angelica E. Graminha d, Antonio G. Ferreira d, Alzir A. Batista d,⁎
a Laboratorio de Síntesis Orgánica, Facultad de Química, Universidad de La Habana, La Habana, Cuba
b Instituto de Química de São Carlos, Universidade de São Paulo, São Carlos, SP, Brazil
c Departamento de Gerontologia, Universidade Federal de São Carlos, São Carlos, SP, Brazil
d Departamento de Química, Universidade Federal de São Carlos, São Carlos, SP, Brazil
a b s t r a c ta r t i c l e i n f o
Article history:
Received 16 July 2013
Received in revised form 29 January 2014
Accepted 30 January 2014
Available online 8 February 2014
Keywords:
Acyl thiourea derivatives
Triphenylphosphine
Pd (II) complexes
X-ray structures
Cytotoxicity
The rational design of anticancer drugs is one of the most promising strategies for increasing their cytotoxicity
and for minimizing their toxicity. Manipulation of the structure of ligands or of complexes represents a strategy
for which is possible to modify the potential mechanism of their action against the cancer cells. Here we present
the cytotoxicity of some new palladium complexes and our intention is to show the importance of non-
coordinated atoms of the ligands in the cytotoxicity of the complexes. New complexes of palladium (II), with
general formulae [Pd(PPh3)2(L)]PF6 or [PdCl(PPh3)(L)], where L = N,N-disubstituted-N′-acyl thioureas, were
synthesized and characterized by elemental analysis, molar conductivity, melting points, IR, NMR(1H, 13C and
31P{1H}) spectroscopy. The spectroscopic data are consistent with the complexes containing an O, S chelated
ligand. The structures of complexes with N,N-dimethyl-N′-benzoylthiourea, N,N-diphenyl-N′-benzoylthiourea,
N,N-diethyl-N′-furoylthiourea, and N,N-diphenyl-N′-furoylthiourea were determined by X-ray crystallography,
conﬁrming the coordination of the ligands with the metal through sulfur and oxygen atoms, forming distorted
square-planar structures. The N,N-disubstituted-N′-acyl thioureas and their complexes were screened with
respect to their antitumor cytotoxicity against DU-145 (human prostate cancer cells), MDA-MB-231 (human
breast cancer cells) and their toxicity against the L929 cell line (health cell line from mouse).
© 2014 Published by Elsevier Inc.
1. Introduction
The success of cisplatin in cancer therapies has triggered great inter-
est to search for more effective antitumor agents, and as a consequence
many other transition metal complexes have been obtained and tested
against tumor cells. The number of metal compounds in current clinical
use for this purpose is very limited and concerns only the platinum
complexes [1]. However, it is important to search for other therapeutic
agents different from those of platinum, which are in clinical use, in
order to overcome the known drawbacks caused by them. Thus, a num-
ber of drug-design strategies have been employed, mainly in the past
twenty years, and literature reports palladium(II) and platinum(II)
complexes of phenylacetaldehyde thiosemicarbazone that are capable
to, in vitro, bind to DNA, and have enhanced capacity to form inter-
strand cross links by comparison with cisplatin [2,3].
The acyl thiourea ligand systems are very versatile and small struc-
tural changes can be readily made that lead to very different chemical
and physical properties. Chelating thiourea ligands containing N, S and
O donor atoms show broad biological activity and the existence of
metal ions bonded to biologically active compounds may enhance
their activities, and it was shown that the mode of binding of platinum
to DNA is affected by the substituent nature on the acyl thiourea [4].
Acyl thiourea derivatives have been increasingly important with a
wide diversity of applications in heterocyclic chemistry, metal com-
plexes, molecular electronics and exhibit an array of biological activities
[5–9]. Some of them are employed as fungicidal, antiviral, antimicrobial
[10], parasiticidal [11], antitumoral [12] and pesticidal agent [13–15].
Indeed cytotoxicity studies using HeLa cancer cell lines have demon-
strated that some of these platinum acyl thioureas show cytotoxic
behavior, with the antiproliferative effects being dependent on the na-
ture/type of the substituent in the acyl thiourea ligand [16–18]. Having
this in mind our research group has been interested in developing new
thiosemicarbazones or similar ligands, including polydentate ones such
as acyl thioureas, containing N, S and O atomswith the capacity to form
transitionmetal complexes. It turns out that these ligands are able to bind
awide variety ofmetal ions in different coordinationmodes, forming sta-
ble complexes. Inmost of the ones containing acyl thioureas, whichwere
structurally characterized, they act as bidentate O,S-monoanionic ligands
[19–22]. Also, it is well known that palladium(II) complexes are potential
candidates to be used as metal based therapeutic agents, since this metal
has a very similar chemistry to that of platinum(II), some of whose
compounds are well known as anticancer agents [23].
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Here we report the synthesis, crystal structures and cytotoxicity
studies of new palladium(II) complexes containing PPh3 and N,N-
disubstituted-N′-acyl thioureas as ligands. The N,N-disubstituted-N′-acyl
thioureas used as ligands in this work were synthesized by the proce-
dure previously reported in literature [24]. Scheme 1 shows the path-
way for the synthesis of the Pd(II) complexes, which were obtained
by reacting methanolic solutions of acyl thioureas with the precursor,
the dichloro(bistriphenylphosphine)palladium(II).
The coordination between acyl thiourea derivatives and the precur-
sor was proceeded by an exchange reaction, which involved deproton-
ation of the acyl thioureido group of the ligands during the complexes
formation [25].
2. Experimental
2.1. Material and measurements
Bis diphenylphosphine palladium(II) chloride was obtained from
Strem. All reagents were purchased with reagent grade and used with-
out further puriﬁcation. Solvents were dried and used freshly distilled,
unless otherwise speciﬁcally indicated.
Thin layer chromatography (TLC)was performedon0.25mmsilica gel
pre-coatedplastic sheets (40/80mm) (Polygram_ SILG/UV254,Macherey
& Nagel, Düren, Germany) using benzene/methanol (9/1) as eluent.
The IR spectrawere recorded on a FTIR Bomem-Michelson 102 spec-
trometer in the 4000–200 cm−1 region using CsI pellets. Conductivity
values were obtained using 1.0 mM solutions of complexes in CH2Cl2,
using a Meter Lab CDM2300 instrument. The molar conductance mea-
surements (Λ) were carried out in dichloromethane at 25 °C, using con-
centrations of 1.0 × 10−3 M for the complexes. 1H, 31P and 13C NMR
were recorded on a Bruker DRX 400 MHz, internally referenced to TMS,
chemical shift (δ), multiplicity (m), spin–spin coupling constant (J), inte-
gral (I). CDCl3 was used as solvent, unless mentioned. The 31P shifts are
reported in relation toH3PO4, 85%. Partial elemental analyseswere carried
out on the Department of Chemistry of the Federal University of São
Carlos— UFSCar, in an instrument of CHNS staff EA 1108 of the FISONS.
2.2. Synthesis of N,N-dialkyl-N′-acyl thioureas
Detailed descriptions of syntheses and characterization of ligands
have been reported elsewhere [24]. A solution of an appropriately acyl
chloride (30 mmol) in acetone (50 mL) was added drop wise to a sus-
pension of KSCN (0.01mol) in acetone (30mL). Themixturewas stirred
until a precipitate appeared (ammonium chloride), indicating the for-
mation of the respective organic isothiocyanate. The corresponding
amine (40 mmol), dissolved in acetone was added, slowly and with
constant stirring to the resulting solution. The solution was cooled in
an ice-water bath and the stirring was continued at room temperature
during 2–9 h, until the reaction was completed (the reaction progress
was monitored by TLC). The reaction mixture was then poured into
600 mL of cold water. The solid N,N-disubstituted-N′-acyl thioureas
were collected by ﬁltration and ﬁnally puriﬁed by recrystallization
from ethanol. The identity of the products was conﬁrmed by comparing
their 1H and 13CNMRdatawith those reported in the literature [24]. The
structures of the ligands are shown in Fig. 1.
2.3. Synthesis of the complexes
The complexeswere obtained from direct reactions of the precursor,
[PdCl2(PPh3)2], with the N,N-disubstituted-N′-acyl thioureas, in
Scheme 1. Pathways for the synthesis of N,N-disubstituted-N′-acyl thioureas Pd (II) complexes, and the R1 and R2 groups present in the ligands.
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methanol solutions. The complexes were separated from the reaction
mixtures as yellow crystalline solids. Filtration and further washing
with hot water and hot hexane were enough to afford pure and stable
compounds, in about 80% yields. Thus, the general procedure for the syn-
thesis of the complexes is described: A solution of [PdCl2(PPh3)2] (1.49
mg; 0.002 mmol) in 5mL ofmethanol, was added dropwise to a solution
of correspondingN,N-dialkyl-N′-acyl thiourea (0.002 mmol), dissolved in
30 mL of the same solvent, and 0.368 g (0.002 mmol) of KPF6. The reac-
tion was heated under magnetic stirring at 80 °C, for 2 h. The
reaction mixture was left in the refrigerator overnight. The yellow solids
obtained were ﬁltered off and washed, successively, with hot water and
hot hexane (3 × 20 mL). The obtained compounds are stable in the air.
The 1H and 13C NMR data, the elemental analyses (calculated
values in parenthesis),melting point temperature andmolar conductivity
(ΛM, 1.0 × 10−3 M in CH2Cl2) for the complexes (1–7) are listed below
and the other data used for the characterization of the complexes will
be ﬁnd in the text:
(1) [PdCl(PPh3)2(N,N-dimethyl-N′-benzoylthioureato-k2O,S)]
NMR 1H, ppm:. 8.07–7.95 (m, 5H, Ph), 7.78–7.22 (m, 5H), 7.21–
7.13 (m, 10H), 3.78 (3H, s, CH3), and .3.76 (3H, s, CH3). NMR
13C; ppm: 162. 68 (C_S); 161.84 (C_O); 133.87, 133.77,
133.40, 131.87, 131.76–116.34 (C\Ph), 43.85 (CH3), 43.61
(CH3); 31P{1H}, 23.39 (s). IR: ν(C_O),1539; ν(C_S), 799;
ν(C_N), 1573 cm−1.
Anal. (%): Found (Calc.): C, 54.92 (55.00); H, 4.18 (4.29); N 4.58
(4.58); S, 5.13 (5.24); MP, 226–228 °C; ΛM=1.4Ω−1 cm2mol−1.
(2) cis-[Pd(PPh3)2(N,N-diethyl-N′-benzoylthioureato-k2O,S)]PF6
NMR 1H; ppm: 8.18–8.07 (m, 1H), 7.96–7.86 (m, 5H), 7.69–7.10
(m, 5H), 7.05–6.92 (m, 10H), 3.84 (d, J= 7.07 Hz, 2H, CH2), 3.46
(d, J= 7.07 Hz, 2H, CH2)1.64 (t, J= 7.02, 7.02 Hz, 3H, CH3), 1.30
(t, J = 7.02, 7.02 Hz, 3H, CH3); NMR 13C; ppm: 170.30 (C_S);
169.86 (C_O); 136.22, 136.18, 135.89, 134.48, 133.82–126.01
(C\Ph), 47.46 (CH2), 46.63 (CH2), 13.13 (CH3), 12.20 (CH3); 31P
{1H}, 26.68; 38.36 (d), 2JP–P = 32.40 Hz. IR: ν(C_O),1528;
ν(C_S), 787; ν(C_N), 1576 cm−1.
Anal. (%): Found (Calc.): C, 54.87 (55.01); H, 4.35 (4.49); N, 2.58
(2.77); S, 3.25 (3.17); MP, 190–193 °C; ΛM=50.4Ω−1 cm2mol−1;
(3) cis-[Pd(PPh3)2(N,N-diphenyl-N′-benzoylthioureato-k2O,S)]PF6
NMR 1H, ppm: 7.43–7.18 (m, 1H), 7.03 (s, 1H), 6.13 (d, J=1.60 Hz,
1H), 6.13–6.01 (m, 1H), NMR 13C, ppm: 174.07. (C_S); 162.92
(C_O); 150.00, 149.93, 146.60, 144.00, 143.57, 134.53–112. 11
(C\Ph). 31P{1H}, 27.63; 37.71 (d), 2JP–P = 29.16 Hz. IR: ν(C_O),
1517; ν(C_S), 784; ν(C_N), 1586 cm−1.
Anal. (%): Found (Calc.): C, 60.59 (60.74); H, 4.19 (4.10); N, 2.45
(2.53); S, 2.83 (2.90); MP, 220–221 °C; ΛM=52.7Ω−1 cm2mol−1.
(4) cis-[Pd(PPh3)2(N, N-dibencyl-N′-benzoylthioureato-k2O,S)]PF6
NMR 1H, ppm: 8.43–8.32 (m, 1H), 7.80–7.40 (m, 1H), 7.10–6.97
(m, 1H), 6.76–6.02 (m, 1H), 5.29 (s, 2H, CH2), 5.06 (s, 2H, CH2).
NMR 13C; ppm: 172.54 (C_S); 170.99 (C_O); 149.96, 149.88,
146.94, 134.64, 134.41–112.06 (C\Ph), 53.93 (CH2), 51.25 (CH2).
31P{1H}, 27.37; 37.95 (d), 2JP–P = 29.97 Hz. IR: ν(C_O),1518;
ν(C_S), 783; ν(C_N), 1576 cm−1.
Anal. (%): Found (Calc.): C, 61.48 (61.35); H, 4.30 (4.35); N, 2.45
(2.47); S, 2.90 (2.82); MP, 160–162 °C; ΛM=48.6Ω−1 cm2mol−1.
(5) cis-[Pd(PPh3)2(N, N-diethyl-N′-furoylthioureato-k2O,S)]PF6
NMR 1H, ppm: 7.78–7.50 (m, 1H), 7.46–6.80 (3H, m, furoyl), 3.12
(2H, c, CH2), 3.09 (2H, c, CH2), 1.31 (3H, t, CH3), 1.06 (3H, t, CH3).
NMR 13C, ppm: 175.92. (C_S), 169.53 (C_O), 161.60, 155.11,
154.29, 153.77–150.16 (C\Ph), 148.02–111.99 (C\Ph and furan
ring), 46.75 (CH2), 46.47 (CH2), 13.18 (CH3) 12.07 (CH3). 31P{1H},
26.63; 38.52 (d), 2JP–P = 32.40 Hz. IR: ν(C_O),1511; ν(C_S),
756; ν(C_N), 1581 cm−1.
Anal. (%): Found (Calc.): C, 55.09 (55.18); H, 4.30 (4.33); N, 2.95
(2.80); S, 3.15 (3.20); MP, 226–228 °C; ΛM=59.6Ω−1 cm2mol−1.
(6) cis-[Pd(PPh3)2(N,N-diphenyl-N′-furoylthioureato-k2O,S)]PF6
NMR 1H, ppm: 7.42–7.03 (m, 1H, Ph), 6.13–6.01 (m, 1H, the furan
ring), NMR 13C ppm: 174.08 (C_S); 162.93 (C_O); 150.01,
149.94, 146.60, 144.03–129.78 and 128.98–112.10 (C\Ph and
furoyl ring). 31P{1H}, 26.78; 38.07 (d), 2JP–P = 30.78 Hz. IR:
ν(C_O),1523; ν(C_S), 769; ν(C_N), 1574 cm−1.
Anal. (%): Found (Calc.): C, 58.95 (59.11); H, 4.00 (3.95); N 2.50
(2.55); S, 2.88 (2.92); MP, 300–302 °C; ΛM=52.8Ω−1 cm2mol−1.
(7) cis-[Pd(PPh3)2(N,N-dibenzyl-N′-furoylthioureato-k2O,S)]PF6
NMR 1H; ppm: 7.92–6.94 (44H, m, C\Ph and furan ring), 5.29 (2H,
s, CH2), 5.10 (2H, s, CH2). NMR 13C; ppm: 173.09. (C_S), 170.99
(C_O), 135.72, 135.29, 135.22, 134.67–129.01 and 128.96–125.79
(C\Ph and furoyl ring). 31P{1H}, 27.41; 37.96 (d), 2JP–P =
30.78 Hz. IR: ν(C_O),1534; ν(C_S), 752; ν(C_N), 1581 cm−1.
Anal. (%): Found (Calc.): C, 59.77 (59.77); H, 4.35 (4.21); N, 2.40
(2.49); S, 2.73 (2.85); MP, 200–202 °C; ΛM=48.6Ω−1 cm2mol−1.
2.4. Crystal structure determination
Single crystals suitable for X-ray diffraction were obtained by slow
evaporation of CHCl3:n-hexane (3:1) solutions of the complexes 1, 3, 4,
5 and 6. Diffraction data were collected on an Enraf-Nonius Kappa-CCD
diffractometer with graphite-monochromated Mo Ka radiation (λ =
0.71073 Å). The ﬁnal unit cell parameters were based on all reﬂections.
Data collections were performed using the COLLECT program [26]; inte-
gration and scaling of the reﬂections were performed with the HKL
Denzo–Scalepack system of programs [27]. Absorption corrections
were carried out using the Gaussian method [28]. The structures were
solved by directmethodswith SHELXS-97 [29]. Themodels were reﬁned
by full-matrix least-squares on F2 by means of SHELXL-97 [30]. The
projection views of the structures were prepared using ORTEP-3 for
Windows [31]. Hydrogen atoms were stereochemically positioned and
reﬁned with the riding model. Data collections and experimental details
Fig. 1. Structures of the N,N-disubstituted-N′-acyl thioureas used as ligands in this work.
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are summarized in Table 1. Relevant interatomic bond lengths and an-
gles are listed in Table 2. Also included are the CCDC deposit numbers
for supplementary crystallographic data.
2.5. Cell culture assay
In vitro cytotoxicity assays on cultured human tumor cell lines still
represent the standard method for the initial screening of antitumoral
agents. Thus, as a ﬁrst step in assessing their pharmacological proper-
ties, the new palladium(II) complexes were assayed against human
breast tumor cell lines MDA-MB-231 (ATCC: HTB-26), DU-145 (ATCC:
HTB-81) and against the L929 cell line (ATCC: CCL 1). The cells MDA-
MB-231 and L929 routinely maintained in Dulbecco's modiﬁed Eagle's
medium (DMEM) supplemented with 10% fetal bovine serum (FBS)
for cell DU-145 were maintained in RPMI-1640 supplemented with
10% FBS, at 37 ºC in a humidiﬁed 5% CO2 atmosphere. After reaching
conﬂuence, the cells were detached by trypsinization and counted. For
the cytotoxicity assay, 1.0 × 104 cells·well−1 were seeded in 200 μL of
complete medium in 96-well assay microplates. The plates were incu-
bated at 37 ºC in 5% CO2 for 24 h to allow cell adhesion. All tested com-
pounds were dissolved in sterile DMSO (stock solution with maximum
concentration of 20 mmol L−1) and diluted to 20; 10; 5.0; 2,5; 0.62;
0.15; 0.039 mmol L−1. From each of these dilute samples 2 μL aliquots
were added to 200 μL medium giving a ﬁnal concentration of
DMSO of approximately 1% and a ﬁnal concentration of the complex
diluted about 100 times. Cells were exposed to the compounds during
a 48 h-period. Cell respiration, as an indicator of cell viability, was
determined by the mitochondrial-dependent reduction of MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to formazan
[32]. MTT solution (0.5 mg/mL) was added to the cell cultures and incu-
bated for 3 h, afterwhich 100 μL of isopropanol was added to dissolve the
precipitated formazan crystals. The conversion of MTT to formazan by
metabolically viable cells was monitored in an automated microplate
reader at 540 nm. The percent cell viability was calculated by dividing
the average absorbance of the cells treated with the test compounds by
that of the control; % cell viability was plotted against drug concentration
(logarithmic scale) to determine the IC50 (drug concentration at which
50% of the cells are viable in relation to the control), with the error esti-
mated from the average of 3 trials.
3. Results and discussion
All the synthesized palladium(II) complexes are of yellow color, and
their elemental analyses, melting point temperatures, and molar con-
ductivities were listed in the experimental section. These data suggest
the formation of [Pd(PPh3)(Cl)(L)] for complex (1) and [Pd(PPh3)2(L)]
PF6 for complexes (2–7), in which L represents the anionic ligand
formed upon deprotonation, when the N,N-disubstituted-N′-acyl
thioureas coordinate to the metal center.
The most useful infrared spectral bands for determining the ligands
mode of coordination are given in the experimental section. The IR spec-
tra of the ligands reveal broad, strong absorption bands in the range of
3053–3267 cm−1, due to NH stretching vibrations. As expected, these
N\H bands present in the free ligands are absent in the IR spectra of
the complexes. On the other hand, the ν(C_N) band, present in the
complexes at 1573–1586 cm−1, is absent in the free ligands, suggesting
the formation of the heterocyclics, in which the nitrogen changes from
sp3 to sp2 hybridization when coordinating to the metal, as shown in
Table 1
Crystal data and reﬁnement parameters for (1), (3), (4), (5) and (6) complexes.
Compound (1) (3) (4) (5) (6)
Empirical formula C28H26ClN2OPPdS C56H45F6N2OP3PdS C58 H49F6N2OP3PdS C46H43F6N2O2P3PdS C54H43F6N2O2P3PdS
Formula weight 611.39 1107.31 1135.36 1001.19 1097.27
Crystal system Monoclinic Triclinic Monoclinic Monoclinic Triclinic
Space group P21/c P-1 P21/n P21/a P-1
a (Å) 14.3350 (5) 11.2530 (7) 15.7849 (8) 11.2500 (4) 11.2080 (2)
b (Å) 11.1240 (5) 11.7780 (8) 13.2553 (7) 29.0220 (16) 11.89.00 (2)
c (Å) 18.1440 (5) 20.7010 (14) 25.2766 (11) 14.1490 (7) 20.5390 (3)
β (°) 110.608 (2) 89.442 (4) 102.264 (3) 92.472 (3) 87.7960 (10)
V (Å3) 2708.15 (17) 2559.4 (3) 5168.0 (4) 4615.3 (4) 2554.94 (7)
Z 4 2 4 4 2
D. calc (mg/m3) 1.500 1.437 1.459 1.441 1.426
Absorption coefﬁcient (mm−1) 0.944 0.561 0.557 0.615 0.562
F(000) 1240 1128 2320 2040 1016
θ range for data collection (°) 2.89 to 26.00 2.61 to 24.82 2.78 to 26.00 2.75 to 22.49 2.62 to 26.00
Index ranges −17 ≤ h ≤ 17 −12 ≤ h ≤ 13 −17 ≤ h ≤ 19 −10 ≤ h ≤ 12 −13 ≤ h ≤ 12
−13 ≤ k ≤ 10 −13 ≤ k ≤ 13 −15 ≤ k ≤ 16 −29 ≤ k ≤ 31 −14 ≤ k ≤ 14
−22 ≤ i ≤ 22 −23 ≤ l ≤ 18 −29 ≤ l ≤ 31 −15 ≤ l ≤ 13 −25 ≤ l ≤ 25
Reﬂections collected 16636 16727 37665 21137 45097
Independent reﬂections (Rint) 5140 (0.0760) 7823 (0.1018) 9539 (0.1124) 6001 (0.1218) 9513 (0.980)
Goodness-of-ﬁt on F2 1.058 1.090 0.945 0.981 1.059
Final R indices
[I N 2σ (I)]
R1 = 0.0429,
wR2 = 0.1070
R1 = 0.0806,
wR2 = 0.2093
R1 = 0.0506,
wR2 = 0.1113
R1 = 0.0578,
wR2 = 0.1171
R1 = 0.051,
wR2 = 0.1624
Largest diff. peak and hole (eÅ)_3 0.343 and−0.669 1.008 and−1.107 0.821 and−0.921 0.430 and−0.395 0.998 and−0.736
CCDC deposit number 842052 842053 931560 842056 842055
Table 2
Selected bond lengths (Å) and angles (°) for the complexes (1), (3), (5–6).
(1) (3) (4) (5) (6)
Bond lengths
Pd\O1 2.081 (2) 2.052 (5) 2.076 (2) 2.018 (5) 2.069 (2)
Pd\P1 2.2509 (8) 2.2571 (19) 2.2580 (10) 2.2612 (18) 2.2611 (8)
Pd\P2 – 2.3516 (19) 2.3403 (11) 2.3512 (19) 2.3389 (8)
Pd\S 2.2474 (10) 2.3026 (18) 2.3108 (11) 2.2945 (19) 2.3067 (8)
Pd\Cl 2.3269 (9) – – – –
S\C 1.733 (4) 1.755 (8) 1.748 (4) 1.727 (8) 1.746 (3)
C1\O1 1.262 (4) 1.248 (9) 1.268 (4) 1.267 (8) 1.244 (4)
N2\C 1.327 (5) 1.300 (9) 1.333 (5) 1.344 (9) 1.322 (4)
N2\C1 1.316 (5) 1.314 (10) 1.320 (5) 1.315 (9) 1.310 (5)
N1\C 1.330 (5) 1.349 (9) 1.344 (4) 1.334 (8) 1.348 (4)
Angles (°)
O1Pd\S 91.30 (7) 91.19 (15) 93.12 (7) 91.55 (15) 91.52 (8)
O1\Pd\P1 175.94 (7) 175.79 (18) 176.77 (8) 177.75 (15) 175.69 (8)
O1\Pd\P2 – 81.96 (15) 82.15 (7) 83.35 (15) 81.95 (8)
S\Pd\P2 – 169.70 (7) 175.06 (3) 174.73 (7) 169.62 (3)
S\Pd\P1 92.52 (4) 90.54 (7) 89.07 (4) 89.85 (7) 90.29 (3)
P2\Pd\P1 – 96.82 (7) 95.72 (4) 95.29 (7) 96.79 (3)
79A.M. Plutín et al. / Journal of Inorganic Biochemistry 134 (2014) 76–82
Scheme 1. The coordination of the metal to the carbonyl group de-
creases the C_O stretching vibration frequency by ca. 180 cm−1,
when compared with the free ligand, in agreement with the literature
[33]. Thus, considering that the free ligands have their ν(C_O) bands
at about 1680 cm−1, it is reasonable to assign the bands in the range
1511–1539 cm−1 to the coordinated C_O group. The absorptions at
815–878 cm−1 in the spectra of free bases, N,N-disubstituted-N′-acyl
thioureas, attributed to the ν(C_S) stretching vibrations, shift to the
752–799 cm−1 range in the complexes spectra. This substantial change
suggests deprotonation of the ligands, indicating coordination through
the sulfur atom with a formally C\S single bond [34–37]. The absorp-
tions at about 470 cm−1 in the IR spectra of the complexes can be
assigned to the M\O vibration mode [38,39] and the assignment of
the Pd\S stretching vibration bands at about 330 cm−1 are in accor-
dance to the reported by Orysyk et al. for palladium(II) complexes
with 1-allyl-3-(2-pyridyl)thioureas [40]. Thus, from the IR data it is
possible to suggest that the N,N-disubstituted-N′-acyl thioureas are at-
tached to the metal through the oxygen and sulfur chelating system.
In the case of complex (1) a chloride ion occupies one coordination
position and the fourth coordination site of the metal is occupied by a
triphenylphosphine, while for the other complexes (2–7) there are
two coordinated triphenylphosphines. The molar conductivity of
complex (1) shows that it is neutral, while complexes (2–7) are anionic
species [41].
The molecular structures of the complexes were also investigated
by NMR (1H, 13C and 31P{1H}) spectroscopy and a comparative analysis
on the basis of the spectroscopic data corresponding to both, free and
coordinated ligands with the metallic ion was carried out.
The 1H NMR data for the complexes (1–7) are given in the experi-
mental section. The 1H NMR integrations and signal multiplicities are
consistent with the proposed and with the X-ray structures. The 1H
NMR spectra of the free ligands show basically three sets of well sepa-
rated signals corresponding to their R1, R2 substituent and to the NH
proton. The signals of the NH protons appear as broad singlets in the re-
gion between 8.35 and 8.80 ppm [24]. The absence of the N\H proton
after the coordination of the ligands to the metal is associated with an
increase in electron density at the C\N bond upon complexation
[42,43]. A slight downﬁeld shift was also observed in the aromatic
Fig. 2. ORTEP view of (1), (3), (4), (5), and (6) complexes showing 50% probability ellipsoids except for (4) which is shown at a 30% level. Hydrogen atoms, the (PF6)− anion and some
labels of the ligands are omitted for clarity.
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protons and in the protons of the nitrogen substituents in the coordinat-
ed ligands, when compared to the chemical shift of the free ligands. The
aromatic protons appear as a complex pattern in the region δ
8.82–6.50 ppm. In the 13C NMR spectra the chemical shifts of the C_S
carbon atoms of the ligands moved up ﬁeld after their coordination to
the metal for all complexes studied, but in the case of the C_O group,
this tendency was not observed for all complexes. The explanation for
this is the fact that with the deprotonation of the secondary amide
and with the formation of a “N = C–S–Ru” species, the sulfur atoms,
and consequently their neighbor carbon atoms, became more shielded
in all complexes, something that does not happen with the carbon
from the carbonyl group, in the same extension. The 31P{1H} NMR spec-
trum of the precursor [PdCl2(PPh3)2] in CH2Cl2 solution shows a singlet
peak for phosphorous atoms at 23.83 ppm. In the spectra of complex (1)
the singlet peak is shifted to 23.39 ppm, in conformitywith the presence
of only one phosphorus species for the complex, in solution. For the
other complexes two doublets arise, at about 27 and 38 ppm, indicating
the presence of two magnetically different phosphorus atoms coordi-
nated to the palladium(II) ion. Thus, considering that for complex (1)
the phosphorus atoms is trans to the oxygen atom from the acyl thio-
urea ligand and that its chemical shifts is 23.39 ppm, it is reasonable
to assign the 31P{1H} chemical shifts of the other complexes (2–7) at
about 27 ppm also to the phosphorus trans to the oxygen atoms and
the chemical shifts at about 38 ppm to the phosphorus trans to the
sulfur atoms from the ligands. Also in the region of−138–158 ppm a
multiple signal of the PF6− functioning as outer-sphere anions for the
complexes obtained is observed, except for complex (1), indicating
that this complex is neutral, in accordance to the molar conductivity
measurements for these complexes (see experimental section). These
data are consistent with those obtained for some palladium(II)
thiosemicarbazones complexes [35].
The structures of complexes (1), (3), (4), (5) and (6) were deter-
mined by X-ray diffraction analysis. Their ORTEP views are in Fig. 2
and selected bond lengths (Å) and angles (°) for the complexes are
listed in Table 2. In the structures of the complexes the N,N-disubstitut-
ed-N′-acyl thioureas adopt a cis conformation, bounded to the central
ion Pd(II) by the oxygen and sulfur atoms, and with two PPh3 ligands,
which are also in the cis fashion, except for the complex (1), which
has just one triphenylphosphine in its structure. In all complexes the
Pd(II) ion is nearly planar, fourfold environment. The thione C_S
bond in the coordinated anionic ligands becomes formally a single
bond making it longer (average = 1.7418 Å) than the C_S bond of
the neutral moieties [24,25], and the N(2)\C bond (average 1.3252 Å)
(Fig. 2, Table 2), which becomes a double bond in the anionic
moieties, is typical for C_N distances [44]. The N(1)\C distance,
1.341 Ả (average), is anionic and in the amine form. Thus the metal
is coordinated to the negatively charged organic molecules, which act
as bidentate ligands, through oxygen (average distance Pd\O =
2.059 Å) and sulfur (average distance Pd\S = 2.2924 Å) atoms. The
Pd\S average distance is close to the ones found for other palladium(II)
thiosemicarbazones complexes [36]. The remaining binding sites are oc-
cupied by triphenylphosphines (average distance Pd–P1 = 2.2577 Å
and Pd–P2 = 2.3455 Å), or by the chloride in the case of complex (1),
where the distance Pd–Cl is 2.3269(9) Ả, which is close to those report-
ed in the literature [36]. The distances for the C\S, C\Nand C\Obonds
in the chelate rings, listed in Table 2, are the characteristic of single and
double bond lengths, respectively [44]. The C\O bond distances are
slightly sensitive to the coordination of the ligand to the metal. In the
case of the bis-triphenylphosphine-N,N-dietyl-N′-furoilthioureato-k2O,
S the C\O distance for the free ligand is 1.226(3) Å (average for two
independent molecules per asymmetric unit), and, 1.2605(4) Å, after
its coordination to the metal [25].
Table 3 lists the ligands and complex concentrations that produce
50% of growth inhibition (IC50, μM) against DU-145 (human prostate
cancer cells), MDA-MB-231 (human breast cancer cells) and against the
L929 cell line (health cell line frommouse). The seven new palladium(II)
complexes, the free ligands and the precursor [PdCl2(PPh3)2], were tested
against the tumor cells and L929 cells. For comparison the cytotoxicity
of cisplatin and of [PdCl2(PPh3)2] were also evaluated under the same ex-
perimental conditions. The IC50 values, calculated from the dose-survival
curves generated by the MTT assays obtained after drug treatment, are
shown in Table 3. It is worth pointing out that the most promising com-
plex is (5), with the N, N-diethyl-N′-furoylthiourea ligand, which had
very low IC50 and was selective for the MDA-MB-231 cells. Additionally,
its IC50 against the L929 cell is very high. It is interesting to observe that
the smaller volume of ligand in complex (5), when compared with the
other complexes, may be the steric factor affecting the enhanced cytotox-
icity of the compound. In this case the low steric effect of the complex can
facilitate its contact with the DNA molecule, while the presence of the
oxygen atom in the furoyl thiourea group allows its interaction through
hydrogen bonding. These preliminary results are very encouraging in
that they support our hypothesis that the non-bonded atoms present in
the ligands can play an important role in the biological activity of the
complex. We are observing this behavior for a series of ruthenium and
platinum complexes and detailed studies are currently underway in our
laboratory to investigate their biological activity and to try to establish a
structure–activity relationship.
4. Conclusions
The preparation of a novel series of Pd(II) complexes with N,N-
disubstituted-N′-acyl thiourea bidentate ligands is here reported.
The X-ray crystallographic characterization shows that these ligands
coordinate with the metal through the oxygen and sulfur atoms. The
complexes exhibit a slightly distorted square-planar geometry corre-
sponding to stoichiometry metal:ligand in 1:1 ratio. In this work there
are two series of complexes: for the ﬁrst one, the complexes (1–4), R1
is the phenyl group and for the other one it is the furoyl one (5–7).
The most promising complex as antitumor agent against the MDA-
MB-231 from the two series here reported is the one where R1 is the
furoyl group and R2 is some of the ethyl groups (5), probably due to
the lower steric hindrance caused by these R2 groups in the contact of
the complex with the DNA molecule. Additionally, the furoyl oxygen
atomallows the electrostatic interaction of the complexwith thebiolog-
ical molecule.
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Table 3
Cytotoxic effect of (L1–L7) ligands and the (1–7) complexes against DU-145, MDA-MB-
231 and L929 cell line, after 48 h of incubation.
Complexes IC50 (μmol L−1)
DU-145 MDA-MB-231 L929
(1) 4.25 ± 0.92 2.15 ± 0.97 b0.8
(2) 7.02 ± 0.81 1.12 ± 0.52 b0.8
(3) N200 N200 N200
(4) N200 N200 N200
(5) 31.85 ± 1.41 b0.8 N200
(6) 68.97 ± 1.64 N200 48.70 ± 13.07
(7) 47.85 ± 1.15 N200 37.12 ± 9.87
(L1) N200 N200 79.11 ± 22.12
(L2) N200 N200 95.71 ± 30.49
(L3) N200 N200 N200
(L4) N200 N200 68.02 ± 1.95
(L5) N200 N200 N200
(L6) 71.36 ± 1.50 N200 N200
(L7)
PPh3
45.57 ± 1.51
N200
N200
N200
82.85 ± 25.88
N200
Cisplatin
[PdCl2(PPh3)2]
2.00 ± 0.47
N200
2.43 ± 0.20
N200
16.53 ± 2.38
N200
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Appendix A. Supplementary data
Supplementary crystallographic data for complexes (1), (3), (4), (5)
and (6) (CCDC 842052, 842053, 931560, 842056, 842055, respectively)
can be obtained free of charge via http://www.ccdc.cam. ac.uk/conts/
retrieving.html, or from the Cambridge Crystallographic Data Centre,
12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336 033; or
e-mail: deposit@ccdc.cam.ac.uk. Supplementary data associated with
this article can be found, in the online version, at http://dx.doi.org/10.
1016/j.poly.2012.02.008.
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